Enterade USA Receives Seed Funding from Florida Institute
Newberry-based health, nutrition and wellness company bringing rehydration technology platform to market
Gainesville and Boca Raton, FL – May 21, 2014 - The Institute for Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Enterade USA, developers of medical foods and products that stabilize GI function and help alleviate side effects experienced by patients undergoing radiotherapy and chemotherapy. The Institute works with Florida’s research universities and institutions to support new company creation and job growth, bridging early funding gaps and enabling them to attract additional private investment capital.
Enterade uses science from the laboratory to create medical foods that combine cutting edge research with the lifestyle demands of patients wanting to gain back their independence and functionality while coping with the debilitating effects of acute/chronic disease states. Its lead product is specially formulated to rapidly replace critical electrolytes and fluids lost due to chronic diarrhea, and helps correct pH in the upper GI, reducing likelihood for nausea.
“By constantly evolving to meet patient needs, Enterade will continue to develop medical foods, diagnostics and therapeutics, which offer patients choice and help support them with their cancer treatments,” said Stephen Gatto, Enterade CEO. “Enterade products promote positive GI health while addressing other disease states such as Cystic Fibrosis, thereby improving the quality of people’s lives in ways that, until now, have not been possible.”
“Testimonials from patients who have ingested Enterade to alleviate the uncomfortable and debilitating side effects of cancer treatment are living proof that the research and discovery taking place at Florida universities can truly improve people’s lives” said Jamie Grooms, CEO of the Institute. “Enterade exemplifies the great work that is being done right in our own backyard, and the Institute is pleased to support their continued growth and success.”
About the Institute
Formed by the Florida Legislature in 2007, the Institute for Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. Over 100 new company projects have been identified across the state, and in the Institute deploys both company building and company funding programs to promising Florida companies. Twenty- eight companies have been funded since the program’s inception.
About Enterade
Enterade USA, LLC is a health, nutrition and wellness company introducing patented and cutting-edge rehydration technology. Our proprietary technology platform utilizes the transport mechanisms in the gastrointestinal (GI) system to stabilize GI function and help alleviate side effects for patients undergoing radiotherapy and chemotherapy. Enterade is a medical food to help stabilize GI function and reduce the incidence of diarrhea, cramping and fluid loss that may accompany cancer therapy or GI conditions for patients under the care of a physician. Physicians, clinicians and patients who have included Enterade as part of a complete treatment paradigm have observed faster, more effective rehydration, thereby enabling the achievement of optimal / maximum dosing for chemotherapy and radiation therapy in individuals with cancer.